BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 18956493)

  • 1. Disclosure to physicians of CAM use by breast cancer patients: findings from the Women's Healthy Eating and Living Study.
    Saxe GA; Madlensky L; Kealey S; Wu DP; Freeman KL; Pierce JP
    Integr Cancer Ther; 2008 Sep; 7(3):122-9. PubMed ID: 18956493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disclosing complementary and alternative medicine use in the medical encounter: a qualitative study in women with breast cancer.
    Adler SR; Fosket JR
    J Fam Pract; 1999 Jun; 48(6):453-8. PubMed ID: 10386489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary and alternative medicine use and its association with quality of life among Lebanese breast cancer patients: a cross-sectional study.
    Naja F; Fadel RA; Alameddine M; Aridi Y; Zarif A; Hariri D; Mugharbel A; Khalil M; Nahleh Z; Tfayli A
    BMC Complement Altern Med; 2015 Dec; 15():444. PubMed ID: 26692096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining the association between patient-centered communication and provider avoidance, CAM use, and CAM-use disclosure.
    Faith J; Thorburn S; Tippens KM
    Altern Ther Health Med; 2015; 21(2):30-5. PubMed ID: 25830278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of CAM use and its correlates in patients with early-stage breast cancer.
    Saquib J; Madlensky L; Kealey S; Saquib N; Natarajan L; Newman VA; Patterson RE; Pierce JP
    Integr Cancer Ther; 2011 Jun; 10(2):138-47. PubMed ID: 21382963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary and alternative medicines (CAM) disclosure to the health care providers: a qualitative insight from Malaysian cancer patients.
    Farooqui M; Hassali MA; Abdul Shatar AK; Shafie AA; Farooqui MA; Saleem F; Aljadhey H
    Complement Ther Clin Pract; 2012 Nov; 18(4):252-6. PubMed ID: 23059441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of women consulting with a complementary and alternative medicine practitioner for pregnancy-related health conditions.
    Steel A; Adams J; Sibbritt D; Broom A; Gallois C; Frawley J
    Women Health; 2014; 54(2):127-44. PubMed ID: 24417673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of complementary and alternative medicine by cancer patients at a Montreal hospital.
    Sewitch MJ; Yaffe M; Maisonneuve J; Prchal J; Ciampi A
    Integr Cancer Ther; 2011 Dec; 10(4):305-11. PubMed ID: 21382961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary and alternative medicine use, spending, and quality of life in early stage breast cancer.
    Wyatt G; Sikorskii A; Wills CE; Su H
    Nurs Res; 2010; 59(1):58-66. PubMed ID: 20010046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary and alternative medicine use by osteoporosis clinic patients.
    Chong CA; Diaz-Granados N; Hawker GA; Jamal S; Josse RG; Cheung AM
    Osteoporos Int; 2007 Nov; 18(11):1547-56. PubMed ID: 17603742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer.
    Henderson JW; Donatelle RJ
    Altern Ther Health Med; 2004; 10(1):52-7. PubMed ID: 14727500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, multicenter study of complementary/alternative medicine (CAM) utilization during definitive radiation for breast cancer.
    Moran MS; Ma S; Jagsi R; Yang TJ; Higgins SA; Weidhaas JB; Wilson LD; Lloyd S; Peschel R; Gaudreau B; Rockwell S
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):40-6. PubMed ID: 22658441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of complementary and alternative medicine among breast cancer patients in Hungary: A descriptive study.
    Sárváry A; Sárváry A
    Complement Ther Clin Pract; 2019 May; 35():195-200. PubMed ID: 31003658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of complementary and alternative therapies by cancer patients in northern Israel.
    Hana G; Bar-Sela G; Zhana D; Mashiach T; Robinson E
    Isr Med Assoc J; 2005 Apr; 7(4):243-7. PubMed ID: 15847205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers to acceptance: an exploratory study of complementary/alternative medicine disuse.
    Jain N; Astin JA
    J Altern Complement Med; 2001 Dec; 7(6):689-96. PubMed ID: 11822617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of complementary and alternative medicine in breast cancer patients and their experiences: a cross-sectional study.
    Tautz E; Momm F; Hasenburg A; Guethlin C
    Eur J Cancer; 2012 Nov; 48(17):3133-9. PubMed ID: 22633625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient disclosure of the use of complementary and alternative medicine to their obstetrician/gynaecologist.
    Harrigan JT
    J Obstet Gynaecol; 2011; 31(1):59-61. PubMed ID: 21280996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nondisclosure of Complementary and Alternative Medicine Use to Primary Care Physicians: Findings From the 2012 National Health Interview Survey.
    Jou J; Johnson PJ
    JAMA Intern Med; 2016 Apr; 176(4):545-6. PubMed ID: 26999670
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of complementary and alternative medicine by patients with cancer in Saudi Arabia.
    Jazieh AR; Al Sudairy R; Abulkhair O; Alaskar A; Al Safi F; Sheblaq N; Young S; Issa M; Tamim H
    J Altern Complement Med; 2012 Nov; 18(11):1045-9. PubMed ID: 22906212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining CAM use disclosure using the Behavioral Model of Health Services Use.
    Faith J; Thorburn S; Tippens KM
    Complement Ther Med; 2013 Oct; 21(5):501-8. PubMed ID: 24050587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.